The study's will contribute to a better understanding of the function and mechanism of ITGB3 in osteosarcoma cisplatin resistance and provide a novel therapeutic target to decrease cisplatin resistance and tumor recurrence in osteosarcoma patients.
Countstar Connection
Researchers relied on Countstar (model not specified) for cell-count measurements in the study's cell samples during cell-culture monitoring.